Evotec SE (EVO)
1.45
-0.01
(-0.68%)
USD |
NASDAQ |
Nov 19, 16:00
1.44
-0.01
(-0.69%)
After-Hours: 20:00
Evotec Enterprise Value : 606.88M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 606.88M |
| November 18, 2026 | 610.43M |
| November 17, 2026 | 617.53M |
| November 16, 2026 | 645.95M |
| November 13, 2026 | 653.05M |
| November 12, 2026 | 681.46M |
| November 11, 2026 | 692.12M |
| November 10, 2026 | 692.12M |
| November 09, 2026 | 709.88M |
| November 06, 2026 | 692.12M |
| November 05, 2026 | 722.31M |
| November 04, 2026 | 649.50M |
| November 03, 2026 | 642.39M |
| November 02, 2026 | 631.74M |
| October 30, 2026 | 635.29M |
| October 29, 2026 | 653.05M |
| October 28, 2026 | 661.93M |
| October 27, 2026 | 649.50M |
| October 26, 2026 | 631.74M |
| October 23, 2026 | 624.63M |
| October 22, 2026 | 638.84M |
| October 21, 2026 | 645.95M |
| October 20, 2026 | 617.53M |
| October 19, 2026 | 596.22M |
| October 16, 2026 | 582.01M |
| Date | Value |
|---|---|
| October 15, 2026 | 596.22M |
| October 14, 2026 | 598.00M |
| October 13, 2026 | 569.58M |
| October 12, 2026 | 578.46M |
| October 09, 2026 | 635.29M |
| October 08, 2026 | 649.50M |
| October 07, 2026 | 663.70M |
| October 06, 2026 | 670.81M |
| October 05, 2026 | 681.46M |
| October 02, 2026 | 660.15M |
| October 01, 2026 | 676.14M |
| September 30, 2026 | 699.22M |
| September 29, 2026 | 594.25M |
| September 28, 2026 | 576.49M |
| September 25, 2026 | 565.83M |
| September 24, 2026 | 555.18M |
| September 23, 2026 | 558.73M |
| September 22, 2026 | 572.94M |
| September 21, 2026 | 558.73M |
| September 18, 2026 | 580.04M |
| September 17, 2026 | 604.90M |
| September 16, 2026 | 590.70M |
| September 15, 2026 | 590.70M |
| September 14, 2026 | 608.45M |
| September 11, 2026 | 626.21M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sartorius AG | 16.99B |
| SCHOTT Pharma AG & Co. KGaA | 3.920B |
| Thermo Fisher Scientific, Inc. | 290.63B |
| Agilent Technologies, Inc. | 51.63B |
| Bio-Rad Laboratories, Inc. | 9.580B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -30.77M |
| Revenue (Quarterly) | 189.75M |
| Total Expenses (Quarterly) | 220.52M |
| EPS Diluted (Quarterly) | -0.0865 |
| Gross Profit Margin (Quarterly) | 12.00% |
| Profit Margin (Quarterly) | -16.22% |
| Earnings Yield | -40.89% |
| Normalized Earnings Yield | -29.81 |